- Real-World Experience with Etanercept Therapy and the Switching Pattern among Korean Patients with Psoriasis after Withdrawal of Etanercept
-
Choi CW, Lee JS, Yu DA, Kim BR, Youn SW
- KMID: 2430800
- Ann Dermatol.
- 2019 Feb;31(1):44-50.
- doi: 10.5021/ad.2019.31.1.44
BACKGROUND: The efficacy and safety of etanercept in the treatment of psoriasis has been proven, and the drug was approved for the treatment of moderate to severe psoriasis. However, there... -
- CITED
-
- Close
- SHARE
-
- Close
- Refractory Plaque Psoriasis Treated with a Combination of Etanercept and Low Dose Methotrexate
-
Lim HS, Yun SJ, Lee JB, Kim SJ, Won YH, Lee SC
- KMID: 2388395
- Korean J Dermatol.
- 2013 Jun;51(6):438-441.
Etanercept has been proven to be highly effective to moderate severe plaque psoriasis. Alternative biologics or combination therapies of etanercept with other systemic agents have been recommended to patients who... -
- CITED
-
- Close
- SHARE
-
- Close
- Recurrent Pneumothorax after Etanercept Therapy in a Rheumatoid Arthritis Patient: A Case Report
-
Kim SH, Choi SJ, Seo YH, Kim JH, Jeong IW, Sohn SB
- KMID: 2172156
- Chonnam Med J.
- 2014 Dec;50(3):115-118.
- doi: 10.4068/cmj.2014.50.3.115
The use of anti-tumor necrosis factor (anti-TNF) agents for rheumatoid arthritis (RA) patients who are refractory to disease-modifying anti-rheumatic drugs is gradually increasing. Etanercept is the first anti-TNF agent to... -
- CITED
-
- Close
- SHARE
-
- Close
- Development of Crohn's Disease during Etanercept Treatment in Juvenile Idiopathic Arthritis
-
Lee H, Choe JY
- KMID: 2222942
- J Rheum Dis.
- 2014 Dec;21(6):340-342.
- doi: 10.4078/jrd.2014.21.6.340
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Etanercept-induced Leukocytoclastic Vasculitis
-
Kim JH, Shin WU, Baek YS, Oh CH, Kim JH
- KMID: 2247310
- Korean J Dermatol.
- 2012 Sep;50(9):807-809.
Leukocytoclastic vasculitis is a small vessel inflammatory disease mediated mostly by deposition of immune complexes. Etanercept (Enbrel(R)) is widely used not only for rheumatic disorders such as ankylosing spondylitis but... -
- CITED
-
- Close
- SHARE
-
- Close
- Long Term Safety and Efficacy of Etanercept in Juvenile Idiopathic Arthritis in a Single Center
-
Bang MH, Kim KN
- KMID: 2451512
- J Rheum Dis.
- 2019 Jul;26(3):200-205.
- doi: 10.4078/jrd.2019.26.3.200
OBJECTIVE: Our aim was to investigate the long term safety and efficacy of etanercept in children with juvenile idiopathic arthritis (JIA). METHODS: The study subjects were the 90 JIA patients treated... -
- CITED
-
- Close
- SHARE
-
- Close
- The efficacy and safety of etanercept in patients with active rheumatoid arthritis receiving methotrexate
-
Choi BR, Kang TY, Joung CI, Lee HS, Uhm WS, Kim TH, Jun JB, Yoo DH, Bae SC
- KMID: 2252656
- Korean J Med.
- 2004 May;66(5):513-520.
BACKGROUND: This study was performed to investigate the efficacy and safety of etanercept in active rheumatoid arthritis patients with stable dose of methotrexate in Korean. METHODS: In a 12 week, single... -
- CITED
-
- Close
- SHARE
-
- Close
- Etanercept in the Treatment of Generalized Annular Pustular Psoriasis
-
Lo Schiavo A, Brancaccio G, Puca RV, Caccavale
- KMID: 2434698
- Ann Dermatol.
- 2012 May;24(2):233-234.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Tumor Necrosis Factor-alpha Inhibitors-induced Pustular Psoriasis
-
Park JJ, Lee SC
- KMID: 2265398
- Ann Dermatol.
- 2010 May;22(2):212-215.
- doi: 10.5021/ad.2010.22.2.212
Anti-tumor necrosis factor (TNF)-alpha agents promise better disease control for the treatment of ankylosing spondylitis resistant to classical disease-modifying treatments. Etanercept, a recombinant human TNF receptor fusion protein, is used... -
- CITED
-
- Close
- SHARE
-
- Close
- TNF Inhibitors and Uveitis in Ankylosing Spondylitis
-
Kim HS, Kim TJ, Bae SC, Yoo DH, Jun JB, Kim TH
- KMID: 2202141
- J Korean Rheum Assoc.
- 2009 Mar;16(1):48-53.
- doi: 10.4078/jkra.2009.16.1.48
Uveitis is the most common extra-articular manifestation of ankylosing spondylitis, and this occurs in 30~50% of the patients with ankylosing spondylitis. The main symptoms of ankylosing spondylitis are usually highly... -
- CITED
-
- Close
- SHARE
-
- Close
- Nodular Vasculitis That Developed during Etanercept (Enbrel) Treatment in a Patient with Psoriasis
-
Park SB, Chang IK, Im M, Lee Y, Kim CD, Seo YJ, Lee JH
- KMID: 2171462
- Ann Dermatol.
- 2015 Oct;27(5):605-607.
- doi: 10.5021/ad.2015.27.5.605
Nodular vasculitis was introduced by Montgomery for cases of erythema induratum-like lesions that were not associated with tuberculosis. Nodular vasculitis has been associated with both nontuberculous infections and noninfectious conditions.... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Sarcoidosis That Improved upon Discontinuation of Etanercept
-
Kang JH, Ahn JH, Yu JE, Kim JE, Yim YR, Lee JW, Lee KE, Park DJ, Wen L, Park YW, Lee SS
- KMID: 2326735
- J Rheum Dis.
- 2016 Jun;23(3):187-192.
- doi: 10.4078/jrd.2016.23.3.187
A 31-year-old man who had been prescribed etanercept over a 3-year period for treatment of ankylosing spondylitis presented with newly developed dry cough, chills, myalgia, and weight loss. Chest computed... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Etanercept on Steroid Refractory Graft-versus-host Disease in Children
-
Han HY, Shin JH, Kim SY
- KMID: 2252099
- Korean J Hematol.
- 2009 Dec;44(4):212-219.
- doi: 10.5045/kjh.2009.44.4.212
BACKGROUND: Etanercept is a recombinant human soluble tumor necrosis factor-alpha (TNF-alpha) receptor fusion protein that inhibits TNF-alpha, a major mediator in the pathogenesis of graft-versus-host disease (GVHD). The purpose of... -
- CITED
-
- Close
- SHARE
-
- Close
- Rheumatoid Arthritis with Secondary Amyloidosis and Chronic Kidney Disease with a Good Response to Etanercept
-
Kim HW, Noh JW, Kim J
- KMID: 2223001
- J Rheum Dis.
- 2013 Dec;20(6):389-392.
- doi: 10.4078/jrd.2013.20.6.389
Secondary amyloidosis is a severe complication of refractory rheumatoid arthritis for which no effective treatment exists. Although the benefits of tumor necrosis factor alpha inhibitors in rheumatoid arthritis treatment are... -
- CITED
-
- Close
- SHARE
-
- Close
- A case of encephalitis in a juvenile rheumatoid arthritis patient treated with etanercept
-
Kwon AR, Park EJ, Kim KH, Kim DS
- KMID: 2281378
- Korean J Pediatr.
- 2010 Feb;53(2):262-266.
- doi: 10.3345/kjp.2010.53.2.262
Tumor necrosis factor-alpha (TNF-alpha) is a major proinflammatory cytokine involved in the pathophysiology of juvenile rheumatoid arthritis. Etanercept is an effective inhibitor of TNF-alpha and has shown a beneficial effect... -
- CITED
-
- Close
- SHARE
-
- Close
- Successful Treatment with Etanercept in a Patient with Adult-onset Still's Disease
-
Woo H, Kim OK, Lee GH, Park JJ, Lee SS, Park YW
- KMID: 2202205
- J Korean Rheum Assoc.
- 2006 Dec;13(4):306-310.
Adult-onset Still's disease (AOSD) is a rare systemic inflammatory disorder of unknown etiology. Non-steroidal anti-inflammatory drugs (NSAIDs), steroids, disease modifying anti-rheumatic drugs (DMARDs), immunosuppressives and intravenous immunoglobulin (IVIG) have been... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Ankylosing Spondylitis Accompanying Sarcoidosis
-
Choi BY, Park YB, Lee JH, Ryu HJ, Lee EY, Lee YJ, Lee EB, Song YW
- KMID: 2202174
- J Korean Rheum Assoc.
- 2007 Sep;14(3):251-255.
- doi: 10.4078/jkra.2007.14.3.251
Sacroiliitis is a rare manifestation in patients with sarcoidosis and there have been several case reports of ankylosing spondylitis (AS) accompanying sarcoidosis. Recently, the development of sarcoidosis has been reported... -
- CITED
-
- Close
- SHARE
-
- Close
- A Clinical Trial of Combination Therapy with Etanercept and Low Dose Cyclosporine for the Treatment of Refractory Psoriasis
-
Lee EJ, Shin MK, Kim NI
- KMID: 2265382
- Ann Dermatol.
- 2010 May;22(2):138-142.
- doi: 10.5021/ad.2010.22.2.138
BACKGROUND: Over the past decade, combination therapies have become a mainstay of dermatologic care in psoriasis. Combination therapies are often more effective and safer than large dose single-agent therapies. With... -
- CITED
-
- Close
- SHARE
-
- Close
- Genetic Variation in the HLA-DRB1 and the Response to Treatment of Rheumatoid Arthritis with Etanercept: Preliminary Study
-
Yun HR, Kang CP, Lee KW, Lee HS, Kim TH, Bae SC
- KMID: 2202277
- J Korean Rheum Assoc.
- 2006 Mar;13(1):10-17.
OBJECTIVE: To investigate the roles of genetic variation in the HLA-DRB1 as predictors of response to etanercept treatment in rheumatoid arthritis (RA) patients. METHODS: Clinical responses of 66 patients treated... -
- CITED
-
- Close
- SHARE
-
- Close
- Interstitial Lung Disease That Occurred during Treatment with Etanercept (Enbrel(R)) of Psoriasis Patients
-
Park SB, Kim HR, Im M, Lee Y, Seo YJ, Lee JH
- KMID: 2246592
- Korean J Dermatol.
- 2013 Sep;51(9):709-712.
Etanercept is widely used to treat autoimmune rheumatic, digestive, and dermatologic diseases such as psoriasis. It acts as a competitive inhibitor of tumor necrosis factor (TNF)-alpha and has acceptable safety... -
- CITED
-
- Close
- SHARE
-
- Close
